Erythrocytosis in hypophosphatemic rickets: irreversible complication due to nephrocalcinosis after vitamin D and phosphate therapy.
A patient with hypophosphatemic vitamin D-resistant rickets developed secondary erythrocytosis during treatment with large doses of vitamin D2 and phosphate. Erythrocytosis was accompanied by a fall in circulating plasma volume and appeared to have developed as a consequence of nephrocalcinosis because it occurred after the appearance of nephrocalcinosis following several episodes of hypercalcemia and hyperphosphatemia. Nephrocalcinosis and erythrocytosis did not disappear even after recovery of renal function. Thus, the present observations point to the importance of preventing these irreversible complications that could cause renal failure, erythrocytosis, and thrombotic events during the management of hypophosphatemic vitamin D-resistant rickets.
Okazaki
R
R
Fourth Department of Internal Medicine, University of Tokyo School of Medicine, Japan.
Matsumoto
T
T
Harada
S
S
Fukomoto
S
S
Motokura
T
T
Ogata
E
E
D000328:Adult; D004872:Ergocalciferols / Q000009:adverse effects; D006801:Humans; D007015:Hypophosphatemia, Familial / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009397:Nephrocalcinosis / Q000150:complications / Q000209:etiology; D010710:Phosphates / Q000009:adverse effects / Q000097:blood; D011086:Polycythemia / Q000209:etiology*
D004872:Ergocalciferols; D010710:Phosphates